Genetic Study of Amyotrophic Lateral Sclerosis in Norway

NCT05119387 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2026-05-19

No results posted yet for this study

Summary

The purpose of this study is to explore the genetic causes relevant for ALS development in Norway.

Conditions

Interventions

OTHER

Observation

Observation of genetic characteristics

Sponsors & Collaborators

  • ALS Norge

    collaborator UNKNOWN
  • Helse Sor-Ost

    collaborator OTHER_GOV
  • Sykehuset Telemark

    lead OTHER_GOV

Principal Investigators

  • Helle Høyer · Telemark Hospital Trust, Norway

Eligibility

Min Age
16 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2030-12-31
Completion
2035-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05119387 on ClinicalTrials.gov